Company Filing History:
Years Active: 2016-2019
Title: Louwe De Vries: Innovator in Pharmaceutical Peptides
Introduction
Louwe De Vries is a notable inventor based in Winsum, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides that have potential therapeutic applications.
Latest Patents
Louwe De Vries holds three patents, with his latest inventions focusing on Angiotensin type 2 (AT2) receptor agonists. These inventions relate to novel pharmaceutically useful peptides, specifically cyclic peptides that act as agonists of the AngII type 2 receptor. The patents further detail the use of these peptides as medicaments, the pharmaceutical compositions that contain them, and their production methods.
Career Highlights
De Vries is associated with Lanthiopep B.V., a company that specializes in the development of peptide-based therapeutics. His work has been instrumental in advancing the understanding and application of AT2 receptor agonists in medicine.
Collaborations
He collaborates with notable colleagues such as Sieger Adriaan Nelemans and Antonius Jacobus Marinus Roks, contributing to a dynamic research environment focused on innovative pharmaceutical solutions.
Conclusion
Louwe De Vries is a prominent figure in the field of pharmaceutical innovation, with a focus on peptide-based therapies. His contributions continue to shape the landscape of medicinal chemistry and therapeutic development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.